Chimeric Antigen Receptors targeting FGFR4 and/or CD276 with CD28 HTM and CSD for childhood rhabdomyosarcoma Read more about Chimeric Antigen Receptors targeting FGFR4 and/or CD276 with CD28 HTM and CSD for childhood rhabdomyosarcoma US Application 63/634,330Filed on 2024-04-15
MONOCLONAL ANTIBODIES THAT BIND THE JUXTA-MEMBRANE REGION OF MESOTHELIN AND USES THEREOF (RO4 antibody) Read more about MONOCLONAL ANTIBODIES THAT BIND THE JUXTA-MEMBRANE REGION OF MESOTHELIN AND USES THEREOF (RO4 antibody) US Application 63/550,703Filed on 2024-02-07
QUANTITATIVE PARTICLE IDENTIFICATION DIGITAL AUTORADIOGRAPHY Read more about QUANTITATIVE PARTICLE IDENTIFICATION DIGITAL AUTORADIOGRAPHY US Application 63/651,184Filed on 2024-05-23
BIVALENT COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME Read more about BIVALENT COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME US Application 63/610,555Filed on 2023-12-15
TREATMENT OF ALVEOLAR SOFT PART SARCOMA (ASPS) WITH ATEZOLIZUMAB Read more about TREATMENT OF ALVEOLAR SOFT PART SARCOMA (ASPS) WITH ATEZOLIZUMAB US Application 63/608,127Filed on 2023-12-08
PREDICTING DNA METHYLATION AND TUMOR TYPES FROM HISTOPATHOLOGY Read more about PREDICTING DNA METHYLATION AND TUMOR TYPES FROM HISTOPATHOLOGY US Application 63/626,277Filed on 2024-01-29
Tixocortol Pivalate for use in the prevention and/or treatment of SARS-CoV-2 infections Read more about Tixocortol Pivalate for use in the prevention and/or treatment of SARS-CoV-2 infections US Application 63/599,446Filed on 2023-11-15
FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF Read more about FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF US Application 63/656,535Filed on 2024-06-05
ENGINEERED RNA DEVICES IN HUMAN T-CELLS TO CONTROL GENE EXPRESSION EXTERNALLY Read more about ENGINEERED RNA DEVICES IN HUMAN T-CELLS TO CONTROL GENE EXPRESSION EXTERNALLY US Application 63/683,318Filed on 2024-08-15
Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate Read more about Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate US Application 18/059,840Filed on 2022-11-29